185 results
Page 6 of 10
8-K
d76t3g
17 Jul 20
DEXTENZA® Sets Billable Insert In-Market Sales Record in June and Company Announces Preliminary Second Quarter 2020 Net Product Revenue
7:34am
8-K
mjfv36x2w8u2rq2lza9b
1 Jul 20
Submission of Matters to a Vote of Security Holders
4:15pm
DEFA14A
mxesvtv04l d88
15 Jun 20
Additional proxy soliciting materials
4:16pm
8-K
EX-1.1
vstgbaibcy2s7yx ty
22 May 20
Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
8:27am
424B5
h25v5i wtiu3won5i
20 May 20
Prospectus supplement for primary offering
4:27pm
424B5
42d9zlgc5ok
19 May 20
Prospectus supplement for primary offering
4:54pm
DEFA14A
5lu9t4pszhtajb
29 Apr 20
Additional proxy soliciting materials
4:27pm
8-K
mqx7lxp1489db5
13 Apr 20
Ocular Therapeutix™ Provides Business Update and Response to COVID-19 Global Pandemic
8:05am
8-K
vgvo2paginnly0 py
14 Jun 19
Submission of Matters to a Vote of Security Holders
8:21am
8-K
EX-10.2
zcb4a20hh xf7eaof
30 May 19
Departure of Directors or Certain Officers
4:07pm
8-K
EX-10.1
qtp2y1
30 May 19
Departure of Directors or Certain Officers
4:07pm